Perceptive Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

$3.83 Billion
Q3 2024

A detailed history of Perceptive Advisors LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 931,851 shares of RCKT stock, worth $13.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

931,851

Previous 1,246,597 25.25%

Holding current value

$13.4 Million

Previous $26.8 Million 35.87%

% of portfolio

0.45%

Previous 0.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $5.54 Million - $8.15 Million	-314,746 Reduced 25.25%	931,851 $17.2 Million
Q2 2024 Aug 14, 2024	SELL	$20.66 - $26.72 $11.5 Million - $14.8 Million	-554,471 Reduced 30.79%	1,246,597 $26.8 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $2.45 Million - $2.88 Million	93,670 Added 5.49%	1,801,068 $48.5 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $3.19 Million - $6.07 Million	189,931 Added 12.52%	1,707,398 $51.2 Million
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $5.26 Million - $8.4 Million	349,104 Added 29.88%	1,517,467 $31.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $4.99 Million - $7.09 Million	300,631 Added 34.65%	1,168,363 $23.2 Million
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $3.32 Million - $4.76 Million	-210,472 Reduced 19.52%	867,732 $14.9 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $8.96 Million - $13.2 Million	578,204 Added 115.64%	1,078,204 $21.1 Million
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $8.25 Million - $12.3 Million	-666,883 Reduced 57.15%	500,000 $7.98 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $4.07 Million - $8.51 Million	-511,207 Reduced 30.46%	1,166,883 $16.1 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $3.7 Million - $6.65 Million	-281,035 Reduced 14.34%	1,678,090 $26.6 Million
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $7.56 Million - $12.6 Million	-351,136 Reduced 15.2%	1,959,125 $42.8 Million
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $12.1 Million - $21.6 Million	-441,342 Reduced 16.04%	2,310,261 $69.1 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $4.58 Million - $5.49 Million	-116,168 Reduced 4.05%	2,751,603 $122 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $22.9 Million - $34.9 Million	-529,096 Reduced 15.58%	2,867,771 $127 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $28.1 Million - $72 Million	1,207,857 Added 55.18%	3,396,867 $186 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $487,743 - $1.26 Million	-50,231 Reduced 2.24%	2,189,010 $30.5 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $2.9 Million - $6.34 Million	261,829 Added 13.24%	2,239,241 $51 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $22.8 Million - $30.1 Million	1,519,239 Added 331.59%	1,977,412 $29.7 Million
Q1 2019 May 15, 2019	BUY	$13.45 - $19.01 $2.93 Million - $4.14 Million	218,000 Added 90.77%	458,173 $8.04 Million
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $2.69 Million - $5.65 Million	240,173 New	240,173 $3.5 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.09B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History